Anticipation

Anticipation is a form of prior art invalidity: a patent claim is anticipated if a single prior art reference discloses every element of the claimed invention: LEGAL STANDARD: for anticipation, a single prior art reference must disclose each and every limitation of the claim, either expressly or inherently; Verdegaal Bros. v. Union Oil (Fed. Cir. 1989): 'A claim is anticipated only if each and every element as set forth in the claim is found, either expressly or inherently described, in a single prior art reference'; SINGLE-REFERENCE RULE: anticipation requires a SINGLE reference — not a combination of multiple references; combining two references to show all elements are disclosed is OBVIOUSNESS under § 103, not anticipation under § 102; ARRANGEMENT REQUIREMENT: the reference must not only disclose every element but must arrange them as claimed; a reference listing all the ingredients of a compound but not teaching their combination is generally not anticipatory; CLAIM-BY-CLAIM ANALYSIS: anticipation is analyzed claim-by-claim; some claims may be anticipated while others survive; LEGAL vs. FACTUAL ISSUES: anticipation = factual question (what does the reference disclose?) reviewed for substantial evidence; claim construction = legal question reviewed de novo; claim construction predates the anticipation comparison; WHO BEARS THE BURDEN: in USPTO examination and PTAB proceedings, the examiner or petitioner establishes a prima facie case; in district court litigation, the party challenging validity bears the burden of clear and convincing evidence.

The America Invents Act (AIA, effective March 16, 2013) fundamentally changed § 102's prior art categories for applications with effective filing dates on or after March 16, 2013: AIA § 102(a)(1) — prior art as of the EFFECTIVE FILING DATE of the claimed invention if: (1) patented — issued in any country; (2) described in a printed publication — anywhere in the world; (3) in public use — in the United States; (4) on sale — in the United States; (5) otherwise available to the public; AIA § 102(a)(2) — patent applications that: (1) are US patents or US patent application publications; (2) name a different inventor; (3) have an earlier effective filing date; AIA § 102(b) — EXCEPTIONS (disclosures that do NOT count as prior art): (1) the 1-YEAR GRACE PERIOD: a disclosure made 1 year or less before the effective filing date does NOT anticipate if the disclosure was made by the inventor or joint inventor (or if the disclosure qualifies as the inventor's own disclosure); (2) own prior disclosure: if the inventor disclosed before the filing, a third party's subsequent identical disclosure within the grace period also doesn't count; PRE-AIA § 102 CATEGORIES (for applications with filing dates before March 16, 2013): § 102(a): known or used by others in US / patented or described in printed publication before invention date; § 102(b): patented or in public use or on sale in US more than 1 year before filing; § 102(e): earlier filed US application by another; § 102(g): prior invention by another not abandoned, suppressed, or concealed; CRITICAL DISTINCTION: pre-AIA § 102 was INVENTION-DATE based (first to invent system); AIA § 102 is FILING-DATE based (first inventor to file system).

Inherent anticipation extends anticipation to elements not expressly disclosed in a prior art reference: INHERENCY DEFINED: a claim element is inherently present in a prior art reference if the reference necessarily results in — or necessarily includes — that element, even if the element is not explicitly mentioned in the reference; STANDARD: 'necessarily' is the key word — the element must be INEVITABLY present, not merely probably or possibly present; Schering Corp. v. Geneva Pharmaceuticals (Fed. Cir. 2003): 'inherency may not be established by probabilities or possibilities; the mere fact that a certain thing may result from a given set of circumstances is not sufficient'; CLASSIC EXAMPLE: if a prior art reference describes a compound, a later patent claims that compound plus its metabolite; the metabolite is inherently formed when the compound is administered — even if the reference didn't mention the metabolite, it was inherently present; Schering: loratadine converted to descarboethoxyloratadine (DCL) metabolite in the human body; even though prior art references did not describe DCL, they inherently disclosed it because it was necessarily formed; KNOWLEDGE NOT REQUIRED: the inherent property need not have been recognized or understood by the prior art reference's author; Titanium Metals Corp. v. Banner: even if the prior art inventor didn't know about the inherent property, the claim is still anticipated; COMPARED TO OBVIOUSNESS: inherency fills in a single missing element of an otherwise-complete prior art reference (anticipation); obviousness combines MULTIPLE references; if a person of skill must recognize the inherency, that recognition cannot supply the obviousness motivation to combine.

Anticipation and obviousness are distinct invalidity doctrines with different legal standards and practical implications: ANTICIPATION (§ 102): a SINGLE prior art reference discloses every element of the claimed invention; if any element is missing from the reference, there is no anticipation; the question is purely factual: what does the reference disclose?; no room for argument about whether skilled artisans would modify the reference — either it's there or it isn't; OBVIOUSNESS (§ 103): multiple references CAN be combined; the combination must have been obvious to a person of ordinary skill in the art (POSITA) at the time of invention; Graham v. John Deere (S.Ct. 1966): four-factor test; KSR International v. Teleflex (S.Ct. 2007): flexible analysis of motivations to combine; secondary considerations (commercial success, long-felt need, failure of others, unexpected results) can rebut obviousness but NOT anticipation; STRATEGIC IMPLICATIONS: (1) a patent owner who wins on anticipation faces no secondary considerations defense — if every element is disclosed, the claim is invalid period; (2) anticipation is 'harder' for challengers — missing even one element saves the claim; (3) obviousness is 'softer' — combining references gives more flexibility to challenge; (4) BOTH CAN BE PLEADED: a validity challenge typically asserts both anticipation and obviousness as alternatives; CLAIM CONSTRUCTION EFFECT: how the claim terms are construed directly determines whether all elements are present in a single reference; narrow construction helps patentees escape anticipation by requiring specific elements the reference lacks.

Patent owners have several arguments to defeat an anticipation rejection or challenge: MISSING ELEMENT ARGUMENT: the most direct defense — show that the prior art reference does NOT disclose at least one element of the claim; analyze each element of the claim vs. the reference; find the element that is absent or not adequately described; CLAIM CONSTRUCTION ARGUMENT: argue for a narrower construction of disputed claim terms such that the reference no longer discloses every element; if a term means X, and the reference discloses Y (where Y ≠ X under the proper construction), anticipation fails; REFERENCE DATE ARGUMENT (pre-AIA): argue the reference is not prior art under the applicable § 102 category — e.g., pre-AIA: the reference was not published before the invention date; the applicant can swear behind a reference with a Rule 131 declaration showing an earlier invention date; CONCEPTION AND REDUCTION TO PRACTICE: pre-AIA only — establish an invention date earlier than the reference's publication date; AIA GRACE PERIOD: show the reference falls within the 1-year grace period AND was the inventor's own disclosure (or derived from the inventor's disclosure); DERIVATION: pre-AIA § 102(f): if the reference's disclosure was derived from the patent owner/inventor, it cannot anticipate; FOREIGN PATENT TIMING: under pre-AIA, foreign patents are prior art as of the date of publication in the foreign country, not the earlier filing date; if the foreign patent published after the inventor's date, it is not prior art; INHERENCY REBUTTAL: if the challenger claims inherency, argue the element is not necessarily present — merely possible or probable, not inevitable.